Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech company focused on artificial intelligence (AI), went public in April ...

I co-created Graph Neural Networks while at Stanford. I recognized early on that this technology was incredibly powerful. Every data point, every observation, every piece of knowledge doesn’t exist in ...

AI drug discovery is not a new phenomenon - but it is evolving at an almost dizzying pace - and Recursion is one of the earliest innovators in the space.

Midcycle redistricting efforts like the ones in Texas and California have, up to now, been extremely uncommon.